histone acetyltransferases, p300 inhibitor, nucleoside scaffold, antitumor
JMJD3, HDAC, Dual inhibitor, antitumor, Structure activity relationship analysis
microplastics, Fungal biodegradation, Adipic acid, LC-MS/MS, method development, Method validation
breast cancer, c-Mesenchymal-to-epithelial transition, Histone deacetylase, Dual inhibitors, antitumor
metagenomic, biomarker, disease prediction, multichannel, 2D-representations, MEGMA, AggMapNet
c-Met, PARP1, Dual target inhibitor, BRCA Wild-Type TNBC
therapeutic response prediction, low-sample, gene expression, deep learning, transcriptome
